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Abstract The levels of selected neuroregulatory proteins
that inhibit or promote apoptotic cell death were measured
in the striatum of piglets subjected to precisely controlled
1 h hypoxic insult followed by 0, 2 and 4 h recovery and
compared to sham operated animals. The anti-apoptotic
proteins: there were increases in Survivin at 0 (157%,
P = 0.031) and 4 h (171%, P = 0.033), in Bcl-XL at 0
(138%, P = 0.028) and 4 h (143%, P = 0.007), in VEGF
at 4 h (185%, P = 0.019) and Hsp27 at 2 h (144%,
P = 0.05) and 4 h (143%, P = 0.05). The pro-apoptotic
proteins: caspases-1 and 7 increased at 4 h (135%, P =
0.05) and (129%, P = 0.038), respectively. Bim increased
after 4 h (115%, P = 0.028), Apoptosis Inducing Factor
after 2 h (127%, P = 0.048) and Calpain after 4 h (143%
of control, P = 0.04). Hypoxia causes increase in levels of
both anti- and pro-apoptotic proteins. Their relative activity
determines the outcome in terms of cell damage and neu-
ronal deﬁcit.
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Introduction
Neonatal brain injury resulting from hypoxia–ischemia is a
most common form of brain damage and can lead to various
neurologicaldisorders[1–3].Hypoxiaisetiologicallylinked
tocerebralpalsy,hearingandvisionloss,mentalretardation,
learning disabilities, attention deﬁcit hyperactivity disorder,
schizophrenia and neuronal migration disorders.
The mechanisms underlying hypoxic-ischemic brain
damage are only partially understood but it is well estab-
lished that following hypoxia–ischemia of neonatal brain,
neuronal death can occurs by both apoptosis and necrosis
[4–6]. However, the relative involvement of necrosis and
apoptosis to the injury that develops after cerebral
hypoxia–ischemia is still not clear [7]. The occurrence of
these processes has been reported to be dependent on the
severity and duration of insult and also on the region and
degree of maturation of the brain [8–10]. Numerous studies
have reported that, following hypoxia–ischemia in the
neonatal brain, there is greater apoptotic than necrotic cell
death and that, in neonates, hypoxia can activate several
pro-apoptotic pathways [9–11]. Some of the pro-apoptotic
regulatory proteins involved in this process include casp-
ases, members of the Bcl-2 protein family such as Bax,
Bad, Bid or Bim, apoptosis inducing factor (AIF), and
calpain-calcium binding protease.
Over-expression of other proteins that can occur fol-
lowing hypoxia–ischemia, such as anti-apoptotic proteins
of the Bcl-2 protein family- Bcl-2 or Bcl-XL, Survivin,
VEGF, hypoxia inducing factor -27 (Hsp-27) are known to
suppress apoptotic cell death.
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ferences in expression of Bcl-2 and Bax (the Bcl-2/Bax
ratio is considered an indicator of apoptotic pathway acti-
vation) in the brain of newborn piglet following 1 h
hypoxia. The Bcl-2/Bax ratio was lower in the striatum
than in other brain regions, suggesting that the striatum
may be particularly susceptible to apoptotic injury.
The purpose of the present investigation was to assess
the responses of other pro- and anti-apoptotic proteins in
the striatum of newborn piglets in the same hypoxia model.
Experimental Procedure
Animal Preparation
Newborn piglets, age 3–5 days, were used for this study.
Anesthesia was induced with 4% isoﬂurane (Novaplus,
Hospira Inc., Lake Forest, IL). Pulse oximetry, ECG and
temperature measurements begun immediately after
induction of anesthesia. A 1.0% lidocaine-HCl (Abbott
Laboratories, North Chicago, IL) was used as a local
anesthetic for tracheotomy and insertion of femoral arterial
and venous lines. A bolus of fentanyl citrate (30 lg/kg)
was administered intravenously (IV). Monitoring of sys-
temic blood pressure and heart rate began immediately
following insertion of the arterial line and blood gas
measurements (pO2, pCO2, pH, glucose, and ions) were
made at regular intervals throughout the procedure. Iso-
ﬂurane was reduced to 1% after tracheotomy and pancu-
ronium (Apothecon, Bristol-Meyers Squibb, Princeton, NJ)
was injected (0.3 mg/kg, IV) to help maintain a balanced
anesthesia and to induce respiratory paralysis. The piglets
were placed on mechanical ventilation (Sechrist Infant
Ventilator, model IV-100 B), isoﬂurane was withdrawn
entirely and piglets were ventilated with a mixture of
oxygen and nitrous oxide (at control condition with
21–22% oxygen and 79–78% nitrous oxide). Anesthesia
was maintained during the experiments using nitrous oxide,
fentanyl (10 lg/kg/h, IV) and pancuronium (0.1 mg/kg,
IV). This model provides a balanced anesthesia using an
inhalation agent (nitrous oxide) for amnesia and analgesia,
a potent fast acting narcotic agent (fentanyl) for primary
analgesia, and a neuromuscular blocking agent (pancuro-
nium) to provide surgical and experimental stillness and
control of ventilation. The piglets were monitored closely
and any increase in heart rate or blood pressure of more
than 10% was treated with supplemental fentanyl at a dose
sufﬁcient to return the values of control levels.
Blood pressure, body temperature, heart rate and end-
tidal CO2 were continuously monitored. Arterial blood
samples were taken every 15 min and blood pH, arterial
CO2 pressure (PaCO2) and arterial oxygen pressure (PaO2)
were measured using a Rapid Lab 850 Analyzer (Bayer).
Hydration was maintained by iv injection of physiological
saline as needed. At the conclusion of the experiments, the
anesthetized animals were euthanized by intravenous
administration of saturated KCl solution. After euthanasia
the brain was quickly removed and placed in 0–4C saline
solution, a medial cut used to separate it into the left and
right halves and the all of the striatum, putamen and caudate
nucleus, dissected out. The striatal tissue was rapidly frozen
by placing it on aluminum foil lying in a bed of powdered
dry ice. The frozen tissue was stored at -80C until use.
All animal use procedures were in strict accordance with
the NIH Guide for the Care and Use of Laboratory Animals
and were approved by the local Animal Care Committee.
Experimental Model
Hypoxia was induced by changing the FiO2 from 21 to 6%,
lowering the mean cortical oxygen pressure to 10 mm Hg
over 20 min and then holding a level of 8 mm Hg for
40 min followed by reoxygenation with 21% FiO2 for 0, 2
or 4 h.
Protein Array (Full Moon Bioscience)
Protein Labeling
Labeling reagent was prepared by adding 100 ll of DMF to
1 mg of biotin reagent was added to a ﬁnal concentration of
10 lg/ll. Labeling buffer was added to a homogenate of
the striatal tissue containing 145 lg protein to bring the
volume to 50 ll and then 2 ll of the biotin/DMF was
added to the protein sample with labeling buffer. The
solution was mixed and incubated at room temperature
(RT) for 2 h with mixing. Twenty ﬁve micro litre of stop
reagent was added and the mixture incubated for 30 min at
RT with mixing.
Coupling
The Antibody Microarrays were submerged in blocking
buffer and shaken for 40 min at RT. The arrays were rinsed
with Milli-Q grade deionized (DI) water and incubated in
the coupling chamber with 145 lg of labeled protein
sample in 6 ml coupling solution on an orbital shaker for
2 h at RT. The slides were removed from the coupling
chamber, washed three times with fresh wash buffer, and
rinsed extensively with DI water.
Detection
Thirty micro litre of Cy3-Streptavidin (1 mg/ml) was
added to a 60-ml bottle containing detection buffer. The
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123arrays were submerged in 30 ml of Cy3-Streptavidin
solution and incubated on an orbital shaker for 45 min at
RT in the dark. The slides were washed three times with
fresh wash buffer and rinsed extensively with DI water.
They were then dried with compressed nitrogen and
scanned on an Axon GenePix Array Scanner.
Data Analysis
Scanned images of microarrays were analyzed using Scion
Image software (NIH). The data are presented as the
mean ± SEM for the density of bands for six independent
experiments in each group. This is an exploratory study. We
did not adjust for type 1 errors and statistical signiﬁcance of
differences were assessed using a two-tailed t test with
P\0.05 considered signiﬁcant. Our hypothesis, that
hypoxia would result in signiﬁcant increase in pro and anti
apoptotic signaling in the striatum, predicts a direction for
the changes in protein levels and a one tailed t test would be
appropriate. However, multiple pro and anti apoptotic
proteins were measured in the same samples and a correc-
tion for multiple comparisons would be appropriate. Using
both the one tailed t test and Bonferroni’s correction for
multiple comparisons, which is generally believed to
underestimate the signiﬁcance, signiﬁcance at the 95% for
any one of the proteins being different from control would
be equivalent to P\0.03 calculated by the two tailed t test.
Results
Effect of Hypoxia on Early Response of Selected
Anti-Apoptotic Proteins in the Striatum of Newborn
Piglets
There were no signiﬁcant differences as compared to sham
operated animals in expression of Bcl-2, Bcl-2a, Bcl-6 and
Bcl-XL. There were, however, signiﬁcant increases in the
levels of several other proteins believed to have signiﬁcant
roles in protection of the brain from hypoxic injury
(Fig. 1a–d). As can be seen in Fig. 1a, at 0 h level of
Survivin increased from 2,749 ± 475 to 4,326 ± 414
arbitrary units (157% of control, P = 0.031) and by 4 h to
4,705 ± 631 arbitrary units (171% of control, P = 0.033).
Similarly, Bcl-XL increased signiﬁcantly as compared to
control at 0 h from 12,807 ± 1,162 to 17,666 ± 1,485
arbitrary units (138% of control, P = 0.028) and 4 h of
recovery to 18,323 ± 1,115 arbitrary units (143% of con-
trol, P = 0.007; Fig. 1b). VEGF was also increased, from
1,382 ± 276 to 2,560 ± 317 arbitrary units (185% of
control, P = 0.019) after 4 h of recovery (Fig. 1c) and
Hsp27 increased from 5,137 ± 859 arbitrary units to
7,379 ± 528 arbitrary units after 2 h of recovery (144% of
control, P = 0.05) and to 7,343 ± 524 arbitrary units after
4 h (143% of control, P = 0.05; Fig. 1d).
Effect of Hypoxia on the Early Response of Selected
Pro-Apoptotic Proteins in the Striatum of Newborn
Piglets
There were no signiﬁcant differences between sham oper-
ated animals and post-hypoxic groups in levels of Caspase-
2, -3, -5, -6, -8 and -9. Increase in expression of Caspase-7
from 1,947 ± 192 arbitrary units to 2,508 ± 136 arbitrary
units was observed at 4 h of post-hypoxic recovery (129%
of control, P = 0.038; Fig. 2a). Similarly, Caspase-1 was
increased signiﬁcantly from 2,878 ± 303 to 3,884 ± 377
arbitrary units after 4 h of recovery (135% of control,
P = 0.05; Fig. 2b). Bim expression was increased after 4 h
from 539 ± 21 to 621 ± 24 arbitrary units (115% of
control, P = 0.028; Fig. 3a). Apoptosis Inducing Factor
was increased after 2 h of recovery from 5,636 ± 485 to
7,130 ± 452 arbitrary units (127% of control, P = 0.048
and at 4 h to 7,643 ± 512 arbitrary units (136% of control,
P = 0.017; Fig. 3b). Calpain was increased from
5,004 ± 691 to 7,181 ± 609 arbitrary units (143% of
control, P = 0.04) after 4 h of recovery (Fig. 3c).
Discussion
Hypoxic/ischemic insult to the brain activates a number of
pathways, some of which, if unopposed, lead to apoptotic
or necrotic neuronal damage while others have a protective
role, in part by countering the former. The data presented in
this paper show that, in the striatum of newborn piglets,
hypoxic insult results in rapid changes in expression of
many proteins believed to regulate the processes that both
promote and prevent apoptotic cell death. Striatum was
chosen for this study because we have shown earlier that
this region is particularly sensitive to hypoxia [12]. This
was manifested by signiﬁcant decrease in Bcl-2/Bax ratio,
an indicator of an increased susceptibility of cells to
apoptosis.
Each protein, reported in this study to undergo signiﬁ-
cant changes in response to hypoxic insult to the brain, is
considered likely to have a signiﬁcant role in determining
the outcome of the apoptotic process. Survivin, VEGF,
Bcl-XL and Hsp27 have been shown to be elevated fol-
lowing the hypoxic episode and all these proteins have
been reported to help protect cells by inhibiting the pro-
cesses leading to apoptotic death.
Survivin is a member of the inhibitor of apoptosis pro-
tein family (IAP family) and is reported to diminish
apoptosis by interfering with the activity of caspase-3,
caspase-7, and caspase-9 [13–16]. Additionally, Survivin
748 Neurochem Res (2011) 36:746–753
123can increase cell survival through its effects on mitosis and
cell cycle progression [17–21]. Conway et al. [22] reported
that hypoxic/ischemic insult in a mouse stroke model
resulted in increased expression of Survivin in the brain
after 2 days of recovery. Our study shows that increase in
expression of this protein occurs immediately after
hypoxia, suggesting that Survivin can act quickly after a
hypoxic insult as well as during prolonged recovery.
Survivin can be upregulated by angiogenic factors,
including vascular endothelial cell growth factor (VEGF;
[23, 24]). Our data show that VEGF expression increased
signiﬁcantly only after 4 h of recovery whereas increase in
expression of Survivin was observed already at the end of
the hypoxic insult (0 h of recovery). Therefore, it can be
suggested that, at least at 0 h of recovery, the increase of
Survivin level occurred independently of VEGF. This is
consistent with the report by Conway et al. [22] that
hypoxia alone can induce Survivin expression in the brain,
and this response is at least partially independent of VEGF.
The increase in VEGF observed after hypoxic insult in
our study is consistent with reports of other investigators
[25–29]. However, the role of this increase on apoptotic
pathways in the newborn brain will require future investi-
gation. VEGF has been reported to have two opposing roles
in the brain. It can have pro-inﬂammatory properties and
increases brain edema and tissue damage following ische-
mia [30]. On the other hand, it can also induce angiogen-
esis and increase vascular permeability [31, 32], and these
would be expected to be neuro-protective by inducing
proliferation of astrocytes and preventing death of dopa-
minergic neurons [33]. As mentioned earlier, VEGF has
been reported to have anti-apoptotic properties by up-reg-
ulation of Survivin, Akt and Bcl-2, key anti-apoptotic
proteins [24, 34–36].
Another anti-apoptotic protein which was increased
during post-hypoxic recovery is Bcl-XL. Bcl-XL has been
proposed as a strong endogenous neuronal survival factor
against neonatal hypoxic-ischemic injury [37]. Bcl-XL is
an integral protein localized primarily in the mitochondrial
membrane and had been shown to diminish cell death by
suppressing release of apoptogenic proteins [38–40].
It was also observed increase in expression of Heat-
shock protein 27 (Hsp27) during post-hypoxic recovery.
Hsp27 has several functions; one of them is regulation of
Fig. 1 Expression of Survivin
(a), Bcl-XL (b), VEGF (c) and
Hsp27 (d) in the striatum of
newborn piglets at 0, 2 and 4 h
of post-hypoxic recovery.
Analysis was of homogenates of
striatal tissue. The data are
presented as the mean ± SEM
for the density of bands for six
independent experiments. The
statistical signiﬁcance of
differences from control were
assessed using a two-tailed t test
with P\0.05 considered
signiﬁcant
Fig. 2 Expression of Caspase-7
(a) and Caspase-1 (b) in the
striatum of newborn piglets at 0,
2 and 4 h of post-hypoxic
recovery. The data are presented
as the mean ± SEM for the
density of bands for six
independent experiments
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123apoptosis. It has been reported that Hsp27 interacts with
outer mitochondrial membranes and, by interfering with
the activation of cytochrome c-Apaf1-dATP complex,
inhibits activation of procaspase-9 [41]. Hsp27 can also
inhibit Daxx apoptotic protein and thus prevent association
of Daxx with Fas and Ask1 [42].
Itappears,notsurprisingly,thatcellsstressedbyhypoxic/
ischemic episode respond by increasing the amount of many
proteinsthat help protect them from serious long term injury
and/or death. These proteins form a coordinated stress
response system designed to counter the deleterious effects
of stressful episode on the cell, and affect almost every facet
ofthecellstructureandmetabolism.Thequestion,therefore,
arises:whatistheresponseofsomepro-apoptoticproteinsin
the striatum of the newborn to hypoxic insult?
In the present study, the levels of caspase-2, -5, -6, -8
and -9 did not change in response to the hypoxic episode
when compared to sham operated animals. In contrast,
caspase-1 and -7, as well as Bim, Apoptosis Inducing
Factor (AIF), and calpain, were all signiﬁcantly increased
in the striatum after hypoxic-ischemic insult. Caspase-3
was not measured in the present study, but we have pre-
viously reported no signiﬁcant changes in expression of
this enzyme following hypoxic insult [12].
The caspase cascade plays a vital role in the induction,
transduction, ampliﬁcation and execution of apoptotic
signals within the cell. Activation of caspases (cysteine
proteases) is an essential component of the process of
apoptosis [43]. Caspases have been reported to be activated
after hypoxia–ischemia [6, 44] and inhibition of caspase
activity has been reported to have neuroprotective effects
in the immature brain [45, 46]. Upon their activation,
through the intrinsic and/or extrinsic pathways, caspases
can destroy essential cellular proteins, promoting con-
trolled cell death. There are two tiers of caspase activation
during apoptosis. Initiator caspases (-2, -8, -9 and -10) are
activated through the apoptosis-signaling pathways and
activate the effector caspases (-3, -6 and -7) which, in an
expanding cascade, carry out the apoptosis. In addition,
caspase-1 can activate inﬂammatory processes. The present
study shows that hypoxic insult activates caspase-1 and -7.
The increased expression of caspase-1 is in agreement with
other studies showing an increase of caspase-1 level in
brain neurons in response to hypoxic insults both in vivo
and in vitro [47, 48]. Caspase-1 catalyzes cleavage of
inactive precursor of IL-1b to generate mature cytokine.
IL-1b acts to initiate inﬂammation, and this contributes to
neuronal injury [49]. Caspase-7 had been generally char-
acterized as an executioner of apoptosis [50]. However,
Lakhani et al. [51] showed that this caspase plays also key
role in the initial phase of apoptosis such as Bax translo-
cation and cytochrome c release. Increase in activation of
caspase-7 is in agreement with Yin et al. [52] who reported
that in a rat pup model of hypoxia–ischemia caused acti-
vation of caspase 7 and also other caspases such as -3, -8
and -9. Lack of increase in expression of caspases-3, -8 and
-9 in our study could be due to differences in severity of the
hypoxic insult, animal age, species of experimental ani-
mals, and anatomical region examined.
When caspase activation is inhibited, neurons can still be
injured through caspase-independent pathways [53, 54].
A major regulatory protein in caspase-independent cell
death pathway is the apoptosis-inducing factor (AIF; [40,
55, 56]). AIF has been shown to increase apoptotic pathway
induced by glutamate or oxidative stress [57, 58], trauma
and ischemia [59, 60]. The present study shown increase in
expression of AIF during post-hypoxic recovery in striatum
of newborn piglets. Data from literature indicated that after
Fig. 3 Expression of Bim (a), AIF (b) and Calpain (c) in the striatum
of newborn piglets at 0, 2 and 4 h of post-hypoxic recovery. The data
are presented as the mean ± SEM for the density of bands for six
independent experiments
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123hypoxic-ischemic insult to the developing brain, AIF and
caspases could act through parallel pathways that can lead
to neuronal death [61, 62]. Observed in our model, increase
in expressions of caspase-1 and -7 and AIF are consistent
with the mechanism(s) of apoptotic injury proposed above
by other investigators [61, 62]. Bim, a pro-apoptotic
member of Bcl-2 family, is another protein up-regulated
following hypoxia. Bim has been reported to play an
important role in neuronal death following neonatal
hypoxia–ischemia [63]. The authors reported that deﬁ-
ciency of the pro-apoptotic BH3-only molecules Bad or
Bim is protective in the Rice–Vannucci model of neonatal
hypoxia–ischemia. The increased level of Bim observed in
our study is in agreement with the reports of other investi-
gators showing that Bim increased following hypoxic-
ischemic insults [64, 65]. Another pro-apoptotic protein that
increased following hypoxia was calpain, calcium binding
protease. This is consistent with the report of Carloni et al.
[66] showing signiﬁcant increase in calpain 30 min after
hypoxia–ischemia in a neonatal rat model. As response to
hypoxia, there is increase in cytoplasmic free calcium
derived from the combined inﬂux of extracellular calcium
and the release of calcium present in the endoplasmic
reticulum (ER; [67]). This can activate calcium dependent
proteins, such as calpain, related to cell death [68, 69].
In conclusion, this study was designed to gain under-
standingofthemetabolicsignalingchangesthatareinitiated
byhypoxicinsultand canleadtocellloss throughapoptosis.
Through understanding the signaling processes associated
with progression toward cellular injury and apoptotic cell
death, it should be possible to design rational protective
interventions. Such protective interventions would be
designed to suppress pro-apoptotic and/or promote anti-
apoptotic signaling. Our results show that 1 h of hypoxic
insult to newborn brain causes increases in the levels of
several proteins which, if unopposed, can promote apoptotic
or necrotic cell death. However, it also leads to increased
levels of regulatory proteins that have protective roles, in
part by countering the effects of the pro-apoptotic proteins.
The ﬁnal outcome, as measured in loss of brain cells and
neuronal function, is determined by the relative activity of
these pro- and anti- apoptotic regulatory processes. Treat-
ments that preferentially favor one or the other process
would be expected to markedly affect the ﬁnal outcome.
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